Skip to main content
. 2020 Jun 3;13(2):203–208. doi: 10.3892/mco.2020.2060

Table I.

Characteristics and surgical details of the control and ketamine groups.

Parameter Control (n=30) Ketamine (n=30) Mean difference (95% CI) P-value
Age (years) 68.7±5.7 67.1±6.1 -1.5 (-4.6 to 1.5) 0.32
Height (cm) 165.9±6.0 166.4±6.3 0.5 (-2.6 to 3.7) 0.74
Weight (kg) 66.0±9.1 69.0±10.5 3.0 (-2.1 to 8.1) 0.24
BMI 23.9±2.7 24.8±2.9 0.9 (-0.5 to 2.4) 0.20
ASA 2 [2, 2] 2 [2, 2] n.a. 0.10
Anesthesia time (min) 224±44 235±37 11 (-10 to 32) 0.30
Surgical period (min) 158±44 169±36 11 (-10 to 31) 0.31
Propofol (mg) 1,055±296 1,285±407a 230 (45 to 414) 0.02
Remifentanil (µg) 2,183±717 2,808±890b 626 (208 to 1044) >0.001
Ketamine (mg) 0 137±25c -137 (-146 to -129) >0.001
Fentanyl (µg) 265±52 272±47 7 (19 to 32) 0.61
Acetaminophen (mg) 805±165 846±184 41 (-49 to 131) 0.37
IVPCA (fentanyl) (µg) 830±115 867±136 37 (-28 to 102) 0.26
Pain intensity (NRS) 1 [0, 3] 0 [0, 2.8] n.a. 0.05

aP<0.05,

bP<0.01 and

cP<0.001 (control vs. ketamine). Data are presented as the mean ± standard deviation or median (minimal, maximum value). Mean difference, ketamine group-control group; CI, confidence interval; ASA, American Society of Anesthesiologists Physical Status Classification Scale; BMI, body mass index; IVPCA, intravenous patient-controlled analgesia; n.a., not analyzed; NRS, numerical rating scale.